A retrospective qualitative report of symptoms and safety from transcranial focused ultrasound for neuromodulation in humans

被引:0
|
作者
Wynn Legon
Sarah Adams
Priya Bansal
Parantap D. Patel
Landon Hobbs
Leo Ai
Jerel K. Mueller
Gregg Meekins
Bernadette T. Gillick
机构
[1] Division of Physical Therapy and Rehabilitation Science,
[2] Department of Rehabilitation Medicine,undefined
[3] School of Medicine,undefined
[4] University of Minnesota,undefined
[5] Department of Neurological Surgery,undefined
[6] School of Medicine,undefined
[7] University of Virginia,undefined
[8] School of Medicine,undefined
[9] University of Virginia,undefined
[10] Department of Neurology,undefined
[11] School of Medicine,undefined
[12] University of Minnesota,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Low intensity transcranial focused ultrasound (LIFU) is a promising method of non-invasive neuromodulation that uses mechanical energy to affect neuronal excitability. LIFU confers high spatial resolution and adjustable focal lengths for precise neuromodulation of discrete regions in the human brain. Before the full potential of low intensity ultrasound for research and clinical application can be investigated, data on the safety of this technique is indicated. Here, we provide an evaluation of the safety of LIFU for human neuromodulation through participant report and neurological assessment with a comparison of symptomology to other forms of non-invasive brain stimulation. Participants (N = 120) that were enrolled in one of seven human ultrasound neuromodulation studies in one laboratory at the University of Minnesota (2015–2017) were queried to complete a follow-up Participant Report of Symptoms questionnaire assessing their self-reported experience and tolerance to participation in LIFU research (Isppa 11.56–17.12 W/cm2) and the perceived relation of symptoms to LIFU. A total of 64/120 participant (53%) responded to follow-up requests to complete the Participant Report of Symptoms questionnaire. None of the participants experienced serious adverse effects. From the post-hoc assessment of safety using the questionnaire, 7/64 reported mild to moderate symptoms, that were perceived as ‘possibly’ or ‘probably’ related to participation in LIFU experiments. These reports included neck pain, problems with attention, muscle twitches and anxiety. The most common unrelated symptoms included sleepiness and neck pain. There were initial transient reports of mild neck pain, scalp tingling and headache that were extinguished upon follow-up. No new symptoms were reported upon follow up out to 1 month. The profile and incidence of symptoms looks to be similar to other forms of non-invasive brain stimulation.
引用
收藏
相关论文
共 50 条
  • [21] Neuromodulation Using Transcranial Focused Ultrasound on the Bilateral Medial Prefrontal Cortex
    Kim, Young Goo
    Kim, Song E.
    Lee, Jihye
    Hwang, Sungeun
    Yoo, Seung-Schik
    Lee, Hyang Woon
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (13)
  • [22] Neuromodulation with single-element transcranial focused ultrasound in human thalamus
    Legon, Wynn
    Ai, Leo
    Bansal, Priya
    Mueller, Jerel K.
    HUMAN BRAIN MAPPING, 2018, 39 (05) : 1995 - 2006
  • [23] Noninvasive Targeted Transcranial Neuromodulation via Focused Ultrasound Gated Drug Release from Nanoemulsions
    Airan, Raag D.
    Meyer, Randall A.
    Ellens, Nicholas P. K.
    Rhodes, Kelly R.
    Farahani, Keyvan
    Pomper, Martin G.
    Kadam, Shilpa D.
    Green, Jordan J.
    NANO LETTERS, 2017, 17 (02) : 652 - 659
  • [24] Intrinsic functional neuron-type selectivity of transcranial focused ultrasound neuromodulation
    Yu, Kai
    Niu, Xiaodan
    Krook-Magnuson, Esther
    He, Bin
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [25] Intrinsic functional neuron-type selectivity of transcranial focused ultrasound neuromodulation
    Kai Yu
    Xiaodan Niu
    Esther Krook-Magnuson
    Bin He
    Nature Communications, 12
  • [26] Transcranial Focused Ultrasound for BOLD fMRI Signal Modulation in Humans
    Ai, Leo
    Mueller, Jerel K.
    Grant, Andrea
    Eryaman, Yigitcan
    Legon, Wynn
    2016 38TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY (EMBC), 2016, : 1758 - 1761
  • [27] Histologic safety of transcranial focused ultrasound neuromodulation and magnetic resonance acoustic radiation force imaging in rhesus macaques and sheep
    Gaur, Pooja
    Casey, Kerriann M.
    Kubanek, Jan
    Li, Ningrui
    Mohammadjavadi, Morteza
    Saenz, Yamil
    Glover, Gary H.
    Bouley, Donna M.
    Pauly, Kim Butts
    BRAIN STIMULATION, 2020, 13 (03) : 804 - 814
  • [28] Human Studies of Transcranial Ultrasound neuromodulation: A systematic review of effectiveness and safety
    Sarica, Can
    Nankoo, Jean-Francois
    Fomenko, Anton
    Grippe, Talyta Cortez
    Yamamoto, Kazuaki
    Samuel, Nardin
    Milano, Vanessa
    Vetkas, Artur
    Darmani, Ghazaleh
    Cizmeci, Mehmet N.
    Lozano, Andres M.
    Chen, Robert
    BRAIN STIMULATION, 2022, 15 (03) : 737 - 746
  • [29] Transcranial Focused Ultrasound Neuromodulation in Psychiatry: Main Characteristics, Current Evidence, and Future Directions
    Keihani, Ahmadreza
    Sanguineti, Claudio
    Chaichian, Omeed
    Huston, Chloe A.
    Moore, Caitlin
    Cheng, Cynthia
    Janssen, Sabine A.
    Donati, Francesco L.
    Mayeli, Ahmad
    Moussawi, Khaled
    Phillips, Mary L.
    Ferrarelli, Fabio
    BRAIN SCIENCES, 2024, 14 (11)
  • [30] Focused ultrasound neuromodulation of the spleen activates an anti-inflammatory response in humans
    Zanos, Stavros
    Ntiloudi, Despoina
    Pellerito, John
    Ramdeo, Richard
    Graf, John
    Wallace, Kirk
    Cotero, Victoria
    Ashe, Jeff
    Moon, Jessica
    Addorisio, Meghan
    Shoudy, David
    Coleman, Thomas R.
    Brines, Michael
    Puleo, Chris
    Tracey, Kevin J.
    Chavan, Sangeeta S.
    BRAIN STIMULATION, 2023, 16 (03) : 703 - 711